$CBT Cashflow Statement | Understand Stock

$CBT

$74.02 +$1.14 (1.56%) Close

$CBT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
Cash Flows from Operating Activities:
Net income (loss)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization
Loss on sale of business and asset impairment charge
Purification Solutions
Total loss on sale of business and asset impairment charge

Gain on bargain purchase of a business
Loss on sale of a business
Gain on sale of land
Deferred tax provision (benefit)
Employee benefit plan settlement
Equity in net income of affiliated companies
Share-based compensation
Other non-cash (income) expense
Cash dividends received from equity affiliates

Changes in assets and liabilities:
Accounts and notes receivable
Inventories
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Income taxes payable
Other liabilities
Cash provided by operating activities
Cash Flows from Investing Activities:
Additions to property, plant and equipment
Proceeds from sale of a business
Asset acquisition
Proceeds from sale of land
Proceeds from insurance settlements
Other
Cash used in investing activities
Cash Flows from Financing Activities:
Increase (decrease) in short-term borrowings
Proceeds from short-term borrowings
Repayments of short-term borrowings
Proceeds from issuance of (repayments of) commercial paper, net
Proceeds from long-term debt, net of issuance costs
Repayments of long-term debt
Purchases of common stock
Proceeds from sales of common stock
Cash dividends paid to noncontrolling interests
Cash dividends paid to common stockholders
Cash provided by (used in) financing activities

Effects of exchange rate changes on cash
Increase (decrease) in cash, cash equivalents
Cash, cash equivalents at beginning of year
Cash, cash equivalents at end of year
Cash and cash equivalents
Restricted cash classified within Prepaid expenses and other current assets
Non-cash investing activities and supplemental cash flow information:
Additions to property, plant and equipment included in Accounts payable and accrued liabilities
Income taxes paid
Interest paid

Comments